IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results

Bulletin Express

08/19

IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.

The current board structure comprises: • Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma • Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu • Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao

The announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1122709213"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1122709213\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1122709213?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-19 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122709213","market":"us","top_or_hot":-1,"title":"IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results","media":"Bulletin Express","content":"<p>IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.</p>\n<p>The current board structure comprises:\n• Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma  \n• Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu  \n• Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao</p>\n<p>The announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIMPACT Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Unaudited Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-19 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.</p>\n<p>The current board structure comprises:\n• Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma  \n• Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu  \n• Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao</p>\n<p>The announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"07630","symbol_name":"英派药业-B","start_time":0,"source_url":"","article_id":"1122709213","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122709213","pubTimestamp":1787129230,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"07630":"英派药业-B"},"translate_title":"IMPACT Therapeutics 定于 2026 年 8 月 31 日召开董事会会议，批准 2026 年上半年未经审计业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07630":1},"content_text":"IMPACT Therapeutics, Inc announced that its board of directors will convene on 31 August 2026 to review and approve the unaudited interim financial results for the six months ended 30 June 2026. The company also intends to authorize the public release of these results following board approval.\nThe current board structure comprises:\n• Executive Directors: Dr. Sui Xiong Cai (also Chief Executive Officer), Dr. Ye Edward Tian and Ms. Ning Ma  \n• Non-Executive Directors: Dr. Cong Xu, Dr. Qiang Xu and Mr. Tao Liu  \n• Independent Non-Executive Directors: Dr. Edward Ming Guo, Mr. Chi Hung Siu and Dr. Liming Shao\nThe announcement was issued in Hong Kong on 19 August 2026 and signed by Executive Director and CEO Dr. Sui Xiong Cai.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}